Fig. 5

Inhibitory effect of lymphoma EXOs on T cell and DCs. a T cell line Th2 and DC cell line DCS were treated with EXOs-derived from OCI-LY3 and SU-DHL-16 for 24 h, and then stained with anti-PD-1 antibody, followed by flow cytometric analysis. b After treatment with DLBCL EXOs at the indicated doses, apoptosis of Th2 cells and DCS cells were assessed by an Annexin V/PI-staining method and flow cytometry analysis. c Western blotting analysis of Th2 cells treated with increasing concentrations of OCI-LY3 EXOs for 24 h